ETR:BAYN - Bayer Stock Price, News & Analysis

€64.61
+1.63 (+2.59 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
€63.91
Now: €64.61
€64.67
50-Day Range
€55.50
MA: €60.30
€64.96
52-Week Range
€52.02
Now: €64.61
€84.38
Volume3.62 million shs
Average VolumeN/A
Market Capitalization$60.25 billion
P/E Ratio106.97
Dividend Yield4.45%
BetaN/A
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University to jointly identify new drug targets for the treatment of pulmonary diseases, such as idiopathic pulmonary fibrosis. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 214 30 1

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.47 billion
Cash Flow€4.29 per share
Book Value€45.61 per share

Profitability

Miscellaneous

Employees111,015
Market Cap$60.25 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.


Bayer (ETR:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the ETR under the ticker symbol "BAYN."

Has Bayer been receiving favorable news coverage?

Press coverage about BAYN stock has been trending negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bayer earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Bayer.

Who are some of Bayer's key competitors?

What other stocks do shareholders of Bayer own?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €64.61.

How big of a company is Bayer?

Bayer has a market capitalization of $60.25 billion and generates $45.47 billion in revenue each year. Bayer employs 111,015 workers across the globe.View Additional Information About Bayer.

What is Bayer's official website?

The official website for Bayer is http://www.bayer.com/.

How can I contact Bayer?

The company can be reached via phone at 49 214 30 1.


MarketBeat Community Rating for Bayer (ETR BAYN)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  47
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel